Washington - Session 2025-2026
Title: Hemp-derived cannabinoids
Concerning hemp-derived cannabinoid products.
| Date | Event | Detail |
|---|---|---|
| 2026-02-24 | Introduced | Bill introduced |
| 2026-02-24 | Status | introduced |
| 2026-02-24 | Latest Action | First reading, referred to Consumer Protection & Business. |
| Bill | Title | Status |
|---|---|---|
| HB 2681 | Cannabis license fees | unknown |
| HB 1941 | Agricultural coops/cannabis | unknown |
| SB 5988 | Opioid treatment prg. fees | unknown |
| HB 1347 | Cannabis testing labs | in_committee |
| SB 5071 | Synthetic opioids/endanger. | in_committee |
| HB 2152 | Cannabis/health facilities | unknown |
| SB 5758 | Cannabis licensees/distance | in_committee |
| SB 6204 | Home cultivation of cannabis | in_committee |